Loading candles…
Sanjivani Parenteral Ltd, incorporated in 1994 and headquartered in Mumbai, is a research-based and export-oriented pharmaceutical company. It specializes in the manufacturing and distribution of parenteral (injectables) and oral solid products, focusing on life-saving drugs. Operating within the pharmaceutical industry, the company serves several geographic markets including India, the Middle East, Africa, Latin America, and CIS countries. With over 25 years of operational experience, Sanjivani Parenteral exports its products to more than 25 countries.
This page is a live market overview for SANJIVANI PARANTERAL LTD. (SANJIVIN) on the BSE. As a listed security, SANJIVANI PARANTERAL LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SANJIVIN before placing trades on tick2trade.
As of the latest feed, SANJIVIN last traded at ₹193.2 on BSE, down ₹9.4 (4.64%) from the previous close of ₹202.6. Today's session range is ₹191.4 – ₹208.95, against a 52-week band of ₹170 – ₹396.95. Traded volume today stands at 9.63K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SANJIVIN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SANJIVIN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SANJIVANI PARANTERAL LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SANJIVIN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SANJIVIN option chain page linked from this overview.
| Date |
|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.